Trust Co. of Toledo NA OH Purchases New Position in DENTSPLY SIRONA Inc. $XRAY

Trust Co. of Toledo NA OH bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 1,672 shares of the medical instruments supplier’s stock, valued at approximately $27,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. increased its holdings in DENTSPLY SIRONA by 15.5% during the 2nd quarter. Blue Trust Inc. now owns 14,499 shares of the medical instruments supplier’s stock worth $230,000 after acquiring an additional 1,945 shares during the period. IFP Advisors Inc increased its holdings in DENTSPLY SIRONA by 924.5% during the 2nd quarter. IFP Advisors Inc now owns 3,811 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 3,439 shares during the period. US Bancorp DE increased its holdings in DENTSPLY SIRONA by 12.0% during the 2nd quarter. US Bancorp DE now owns 61,827 shares of the medical instruments supplier’s stock worth $982,000 after acquiring an additional 6,604 shares during the period. KLP Kapitalforvaltning AS increased its holdings in DENTSPLY SIRONA by 11.6% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 42,200 shares of the medical instruments supplier’s stock worth $676,000 after acquiring an additional 4,400 shares during the period. Finally, New Century Financial Group LLC bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $1,129,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Up 3.2%

Shares of XRAY opened at $12.21 on Tuesday. The stock has a market capitalization of $2.44 billion, a P/E ratio of -2.58, a PEG ratio of 0.74 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm has a fifty day simple moving average of $13.45 and a two-hundred day simple moving average of $14.57. DENTSPLY SIRONA Inc. has a twelve month low of $11.69 and a twelve month high of $24.93.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. During the same period last year, the company posted $0.49 EPS. The company’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -13.50%.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of research analyst reports. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Finally, Wall Street Zen raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, September 26th. Two analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $18.00.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.